Farther Finance Advisors »

Theravance Biopharma shares owned by Farther Finance Advisors

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Farther Finance Advisors from 13F filings

Historical chart of Farther Finance Advisors investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by Farther Finance Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by Farther Finance Advisors

Quarter filed Position value Share count Share price at filing
2024-12-31 $215 23 9.39
2024-09-30 $185 23 8.04
2024-06-30 $195 23 8.52
2024-03-31 $208 23 9.04
2023-12-31 $302 27 11.22
2023-09-30 $232 27 8.63

More positions owned by Farther Finance Advisors

Ishares Core S&p 500 Etf Etf (IVV)
Vanguard S&p 500 Etf Etf (VOO)
Ishares Core Total Usd Bond Market Etf Etf (IUSB)
Apple Stock (AAPL)
Microsoft Corp Stock (MSFT)
Ishares National Muni Bond Etf Etf (MUB)
Nvidia Corporation Stock (NVDA)
Vanguard Intermediate-term Bond Etf Etf (BIV)
Amazon Stock (AMZN)
Spdr S&p 500 Etf Trust Etf (SPY)
Ishares Msci Usa Quality Factor Etf Etf (QUAL)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Ishares U.s. Equity Factor Rotation Active Etf Etf (DYNF)
Ishares S&p 500 Growth Etf Etf (IVW)
Ishares Core S&p Small Cap Etf Etf (IJR)

View all positions for Farther Finance Advisors

Top funds holding Theravance Biopharma

Madison Avenue Partners
Weiss Asset Management LP[1
Newtyn Management
BlackRock
Irenic Capital Management
Vanguard Group
Park West Asset Management
State Street Corporation
Oasis Management
Camber Capital Management
Geode Capital Management
D. E. Shaw & Co
Pictet Asset Management Holding SA
Dimensional Fund Advisors
Nuveen Asset Management

View all funds holding Theravance Biopharma